Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Economic Burden of Adverse Events Associated With Follow-Up Frequency Among Patients With Metastatic Melanoma

NCT03165409 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT03165409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Economic Burden of Adverse Events Associated With Follow-Up Frequency Among Patients With Metastatic Melanoma
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
February 27, 2017
Completion date
September 30, 2017
Enrollment
1,828 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma